These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6214261)

  • 41. Acetylator phenotypes in rheumatoid arthritis patients with or without adverse drug reactions to sodium-aurothiomalate or d-penicillamine.
    Rantapää Dahlqvist S; Mjörndal T
    Scand J Rheumatol; 1987; 16(4):235-9. PubMed ID: 3114874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug-induced IgA deficiency in rheumatoid arthritis.
    Stanworth DR; Williamson JP; Shadforth M; Felix-Davies D; Thompson R
    Lancet; 1977 May; 1(8019):1001-2. PubMed ID: 67433
    [No Abstract]   [Full Text] [Related]  

  • 43. Penicillamine compared to previous chrysotherapy in rheumatoid arthritis.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    J Rheumatol; 1983 Apr; 10(2):319-22. PubMed ID: 6864688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. D-penicillamine: chemistry and clinical use in rheumatic disease.
    Howard-Lock HE; Lock CJ; Mewa A; Kean WF
    Semin Arthritis Rheum; 1986 May; 15(4):261-81. PubMed ID: 2940684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gold therapy in rheumatoid arthritis.
    Schorn D; Anderson IF
    S Afr Med J; 1975 Aug; 49(37):1505-6. PubMed ID: 125934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate.
    Svensson A; Theander J
    Ann Rheum Dis; 1992 Mar; 51(3):326-9. PubMed ID: 1533505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gold sodium thiomalate and D-penicillamine. A controlled, comparative study in patients with pauciarticular and polyarticular juvenile rheumatoid arthritis.
    Kvien TK; Høyeraal HM; Sandstad B
    Scand J Rheumatol; 1985; 14(4):346-54. PubMed ID: 3936167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toxicity to D-penicillamine in rheumatoid arthritis.
    Magnus JH; Gran JT; Mikkelsen K; Nygaard H; Brath HK
    Scand J Rheumatol; 1987; 16(6):441-4. PubMed ID: 2962277
    [No Abstract]   [Full Text] [Related]  

  • 49. [Gold compounds and D-penicillamine for therapy of rheumatoid arthritis].
    Miyamoto S; Inoue T
    Nihon Rinsho; 1992 Mar; 50(3):515-20. PubMed ID: 1588740
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HLA-D antigens in rheumatoid arthritis and toxicity to gold and penicillamine.
    Nuotio P; Nissilä M; Ilonen J
    Scand J Rheumatol; 1986; 15(3):255-8. PubMed ID: 3492038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Is myositis in chronic polyarthritis using d-penicillamine drug-induced?].
    Schlumpf U; Bussmann HU; Jerusalem F
    Schweiz Med Wochenschr; 1981 Jan; 111(1):29-35. PubMed ID: 6782670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP
    Can Med Assoc J; 1980 Feb; 122(4):405-15. PubMed ID: 6768438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [HLA antigens and side effects of gold and D-penicillamine in chronic polyarthritis].
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb N
    Wien Klin Wochenschr Suppl; 1984; 156():51-2. PubMed ID: 6442059
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparative toxicity of gold preparations in treatment of rheumatoid arthritis.
    Lawrence JS
    Ann Rheum Dis; 1976 Apr; 35(2):171-3. PubMed ID: 821403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Azathioprine versus D-penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold.
    Paulus HE; Williams HJ; Ward JR; Reading JC; Egger MJ; Coleman ML; Samuelson CO; Willkens RF; Guttadauria M; Alarcón GS
    Arthritis Rheum; 1984 Jul; 27(7):721-7. PubMed ID: 6378208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proteinuria in rheumatoid arthritis--drug-induced or amyloid?
    Bourke BE; Woodrow DF; Scott JT
    Ann Rheum Dis; 1981 Jun; 40(3):240-4. PubMed ID: 6787994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate.
    Rodriguez-Pérez M; González-Dominguez J; Matarán L; Garcia-Pérez S; Salvatierra D
    J Rheumatol; 1994 Jan; 21(1):41-3. PubMed ID: 8151585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship of gold and penicillamine therapy to diffuse interstitial lung disease.
    Scott DL; Bradby GV; Aitman TJ; Zaphiropoulos GC; Hawkins CF
    Ann Rheum Dis; 1981 Apr; 40(2):136-41. PubMed ID: 6784683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Auranofin in rheumatoid arthritis: use in patients with side-effects or lack of effect to gold sodium thiomalate or gold thioglucose and/or D-penicillamine. A prospective one year investigation.
    Manthorpe R; Tvede N; Bendixen G
    Scand J Rheumatol; 1988; 17(5):401-5. PubMed ID: 3145556
    [No Abstract]   [Full Text] [Related]  

  • 60. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    Clin Invest Med; 1984; 7(1):59-63. PubMed ID: 6723126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.